Dose-dependent effect of tamoxifen in tamoxifen-resistant breast cancer cells via stimulation by the ERK1/2 and AKT signaling pathways

Author：                  

Publisher： Spandidos Publications

ISSN： 1021-335X

Source： Oncology Reports, Vol.29, Iss.4, 2013-01, pp. : 1563-1569

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Differential effect of EGFR inhibitors on tamoxifen-resistant breast cancer cells

By          

Oncology Reports, Vol. 34, Iss. 3, 2015-01 ,pp. : 1613-1619

Spandidos Publications

Access to resources Recommend Favorite

Estrogen receptor α is the major driving factor for growth in tamoxifen-resistant breast cancer and supported by HER/ERK signaling

By Thrane Susan  

Breast Cancer Research and Treatment, Vol. 139, Iss. 1, 2013-05 ,pp. : 71-80

Springer Publishing Company

Access to resources Recommend Favorite

Activation of mitogenic pathways and sensitization to estrogen-induced apoptosis: two independent characteristics of tamoxifen-resistant breast cancer cells?

By Scherbakov Alexander   Lobanova Yulia   Shatskaya Valentina   Onopchenko Oksana   Gershtein Elena   Krasil’nikov Mikhail  

Breast Cancer Research and Treatment, Vol. 100, Iss. 1, 2006-11 ,pp. : 1-11

Springer Publishing Company

Access to resources Recommend Favorite

Role of PTEN promoter methylation in tamoxifen-resistant breast cancer cells

By Phuong Nguyen  

Breast Cancer Research and Treatment, Vol. 130, Iss. 1, 2011-11 ,pp. : 73-83

Springer Publishing Company

Access to resources Recommend Favorite

Role of PKC-ERK signaling in tamoxifen-induced apoptosis and tamoxifen resistance in human breast cancer cells

By              

Oncology Reports, Vol. 27, Iss. 6, 2012-01 ,pp. : 1879-1886

Spandidos Publications

Access to resources Recommend Favorite